Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-18-001042

Director sold 1,000 shares at $14.62 ($14,620)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nash Duane Director 2018-02-15 Sale −1,000 $14.62 $14,620 21,499 D: show line 1 in the form
Open-market sales · 1,000 sh · avg $14.62 · $14,620
Loading xslF345X03/primarydocument.xml…